Korenberg Matthew E sold LGND
May 14, 2024 · Form 4 insider transaction
Korenberg Matthew E sold 13,638 shares of Ligand Pharmaceuticals Incorporated at $85.08 per share, a transaction worth $1.16M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
13,638
Price
$85.08
Total value
$1.16M
InsiderKorenberg Matthew E
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMay 14, 2024
Filing dateMay 15, 2024
Shares owned after86,783
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $84.5950 to $85.5500. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.